What is it about?
Anti-emesis - Amrubicin monotherapy- Granisetron -Metoclopramide-Moderately emetic-risk chemotherapy.
Featured Image
Why is it important?
AMR-induced nausea and vomiting have not been definitively evaluated, and antiemetic therapy for AMR has yet to be established. This study retrospectively evaluated the antiemetic effects of granisetron or metoclopramide during AMR monotherapy.
Perspectives
metoclopramide are feasible options for use as anti-emesis during AMR monotherapy.
Takeshi Aoyama
Gan Kenkyukai
Read the Original
This page is a summary of: Antiemetic Effects of Granisetron or Metoclopramide Administered Prior to Amrubicin Monotherapy, Oncomedicine, January 2017, Ivyspring International Publisher,
DOI: 10.7150/oncm.17486.
You can read the full text:
Contributors
The following have contributed to this page
